ABTECT - Maintenance
Condition: Ulcerative Colitis · Sponsor: Abivax S.A.
About this study
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (413)
| Digestive Health Specialists of the Southeast | Dothan, Alabama, United States | — |
| Research Solutions of Arizona, PC | Litchfield Park, Arizona, United States | — |
| GI Alliance | Sun City, Arizona, United States | — |
| University of Arizona | Tucson, Arizona, United States | — |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Citrus Valley Gastroenterology | Covina, California, United States | — |
| University of California (San Diego) | La Jolla, California, United States | — |
| United Medical Doctors | Murrieta, California, United States | — |
| California Medical Research Associates Inc. | Northridge, California, United States | — |
| Clinnova Research Solutions | Orange, California, United States | — |
| Clinical Applications Laboratories | San Diego, California, United States | — |
| Kaiser Foundation Research Institute, a Division of Kaiser Permanente Hospitals | Aurora, Colorado, United States | — |
+ 401 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05535946